Back/Palisade Bio Supports PALI: Empowering Advocacy for 100 Million Asthma and Allergy Patients
healthcare·January 18, 2026·pali

Palisade Bio Supports PALI: Empowering Advocacy for 100 Million Asthma and Allergy Patients

ED
Editorial
Cashu Markets·3 min read
TL;DR
  • Palisade Bio supports the Allergy & Asthma Network's initiative to empower over 100 million Americans with asthma and allergies.
  • The Patient Advocacy Leadership Initiative (PALI) provides training to help patients engage in healthcare policy discussions effectively.
  • PALI aims to elevate patient voices, ensuring their needs are prioritized in evolving healthcare policies.

### Empowering Patient Advocacy: A New Initiative for Asthma and Allergy Awareness

In a significant development for patient advocacy, the Allergy & Asthma Network launches the Patient Advocacy Leadership Initiative (PALI), targeting the empowerment of over 100 million Americans living with asthma, allergies, and related conditions. This initiative is designed to enable patients, caregivers, and families to actively engage in healthcare policy discussions and influence decision-making at various levels. By providing essential training and resources, PALI equips participants to navigate the complexities of healthcare advocacy, addressing the ongoing barriers many face in accessing vital care and medications.

CEO Lynda Mitchell emphasizes that PALI represents a strategic investment in building a robust advocacy community, which is crucial for expanding care access and prioritizing the needs of those affected by asthma and allergies. The initiative’s training program covers a wide range of topics, including understanding the legislative process, crafting compelling advocacy messages, and effectively engaging with policymakers. Participants will have the opportunity to attend Allergy & Asthma Day Capitol Hill (AADCH), which underscores the initiative's commitment to creating informed advocates who can directly influence healthcare policies.

Nissa Shaffi, the Director of Advocacy, highlights the importance of centering the voices of patients and caregivers, who are often the most knowledgeable about the daily impact of asthma and allergies. Through PALI, the Allergy & Asthma Network aims to cultivate a network of patient advocates, empowering them to articulate their experiences and drive meaningful change in the healthcare landscape. As healthcare policies continue to evolve, the initiative seeks to ensure that the needs of affected communities are front and center, fostering a system that responds more effectively to their real-world challenges.

In addition to the advocacy training and policy engagement components, PALI builds upon the Allergy & Asthma Network's 40-year legacy of promoting awareness and access to treatment. This legacy is foundational to the organization’s mission, which has historically included partnerships with various stakeholders to support research funding and improve patient outcomes. The launch of PALI marks a pivotal moment in the ongoing effort to elevate the voices of those living with asthma and allergies, enhancing their ability to influence the policies that directly affect their lives.

As the healthcare landscape continues to shift, the establishment of PALI signals a growing recognition of the need for patient-centered advocacy. By empowering individuals affected by asthma and allergies, the Allergy & Asthma Network not only strengthens community ties but also paves the way for a more inclusive healthcare policy framework that prioritizes the experiences and challenges of those most impacted by these conditions.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...